Early Alzheimer's Disease Clinical Trial
Official title:
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
The primary objective of the study is to evaluate the effects of hepatic impairment on the pharmacokinetics (PK) of E2609 after a single dose administration.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04693520 -
Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease
|
Phase 2 | |
| Recruiting |
NCT05122598 -
Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease
|
Phase 2 | |
| Active, not recruiting |
NCT04770220 -
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
|
Phase 3 | |
| Active, not recruiting |
NCT04777396 -
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
|
Phase 3 | |
| Active, not recruiting |
NCT03887455 -
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
|
Phase 3 | |
| Recruiting |
NCT05531656 -
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
|
Phase 2 | |
| Recruiting |
NCT04599764 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Early Alzheimer's Disease
|
N/A | |
| Completed |
NCT05161715 -
Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease
|
Phase 2 | |
| Enrolling by invitation |
NCT06304883 -
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
|
Phase 3 |